查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999253

血液透析和腹膜透析市場：按治療類型、方法、技術、產品類型、患者類型和最終用戶分類－2026年至2032年全球市場預測

Hemodialysis & Peritoneal Dialysis Market by Treatment Type, Modality, Technology, Product Type, Patient Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血液透析和腹膜透析市場價值將達到 959.1 億美元，到 2026 年將成長至 1,025 億美元，到 2032 年將達到 1,617.3 億美元，複合年成長率為 7.74%。

主要市場統計數據
基準年 2025 959.1億美元
預計年份：2026年 1025億美元
預測年份 2032 1617.3億美元
複合年成長率 (%) 7.74%

簡要概述正在重塑透析護理服務體系和相關人員優先事項的臨床、技術和營運趨勢。

由於技術進步、護理模式的轉變、人口壓力以及監管改革，腎衰竭治療格局正在發生顯著變化。儘管血液透析在許多醫療系統中仍然是腎臟替代療法的基石，但腹膜透析因其以患者為中心的優勢（例如患者自主性和減輕醫療機構負擔）而重新受到關注。設備自動化、透析液配方和血管通路管理的進步不斷改善臨床實務。同時，基於價值的支付模式和居家照護獎勵正在重塑醫療服務提供者的獎勵機制。

居家照護策略、先進設備的引入以及對永續性的需求如何共同作用，重塑護理服務模式、供應商優先事項和支付方獎勵。

在透析領域，變革正在發生，這些變革影響著臨床路徑、護理服務地點和供應商生態系統。居家照護的日益普及是其中最顯著的變化之一，這得益於設備人體工學的改進、遠端患者監護以及系統的看護者培訓計畫。這種居家照護的轉變正在改變使用模式，催生對小型化、易用型設備的需求，並重新定義以遠端支援和物流為重點的服務模式。

對 2025 年實施的費用修訂如何重組整個透析價值鏈的採購、籌資策略和產品設計進行全面評估。

美國2025年實施的關稅制度正在影響整個透析價值鏈的採購決策、供應商網路和成本結構。進口關稅和基於關稅的監管調整使得籌資策略備受關注，迫使醫療服務提供者和製造商實現供應商多元化、採用近岸生產模式，並重新評估其庫存管理政策。這些變化對透析機、監控系統和管路組件等零件密集型產品類型的影響尤其顯著，而國際供應鏈歷來在這些產品類別中扮演核心角色。

基於精確細分的智慧，將臨床模式、產品特性、終端用戶管道和患者群體與最佳化目標定位的策略要求連結起來。

細分市場層面的洞察揭示了不同治療類型、模式、技術、產品類型、最終用戶和患者群體之間的不同趨勢，指南有針對性的策略方法。基於治療類型，血液透析和腹膜透析之間的比較趨勢凸顯了營運規模和患者體驗的差異。在腹膜透析領域，自動化腹膜透析和連續移動腹膜透析之間的模式差異會影響設備的複雜性、培訓強度以及遠端監測的需求。基於模式，居家照護和機構照護之間的差異決定了從資金分配到人員配備模式的方方面面，其中居家照護類別進一步細分為「輔助照護」和「自我護理」路徑，每種路徑都有不同的臨床管治和報銷規定。

在全球範圍內，區域醫療保健系統、報銷機制和供應鏈現狀如何影響不同的市場進入路徑和市場進入優先事項？

區域趨勢持續對整體透析護理領域的技術應用、報銷機制和營運模式產生決定性影響。在美洲，整合的醫療保健系統、成熟的透析服務提供者網路以及強調以價值為導向的醫療政策，推動了對可擴展的院內效率提升工具的需求，同時也提高了人們對能夠減輕醫療機構負擔的居家透析模式的興趣。相較之下，歐洲、中東和非洲地區不同的報銷環境和法規結構則影響先進技術的應用速度。一些地區，尤其是那些優先考慮慢性病管理和遠距醫療基礎設施的市場，正在經歷快速的技術應用。

競爭對手的行動和策略性投資表明，我們正在向一體化產品和服務平台、臨床證據的創造以及區域業務基礎的擴張做出明確轉變。

透析生態系統中的主要企業正致力於透過臨床差異化、平台整合和服務型模式相結合的方式來維持成長並保障利潤率。產品創新重點在於更小巧、更直覺的家用透析設備、能夠提升生物相容性和清除率的先進透析器材料，以及支援遠距治療調整和早期療育的整合式監測系統。此外，各公司還將培訓項目、物流管理以及與醫療服務提供者基於療效的夥伴關係納入其服務組合，這反映了他們對永續價值的認知：永續價值往往在於設備性能與持續臨床支援之間的相互作用。

為製造商、醫療保健提供者、保險公司和供應鏈領導者提供可操作的策略重點，以增強韌性並加速治療方法的轉變。

行業領導者應優先採取一系列有針對性的舉措，以克服當前面臨的挑戰，並在透析護理的各個領域抓住新的機會。製造商應加快模組化設計的研發，以減少對價格敏感型組件的依賴，簡化現場維護，同時增強數位遙測功能，以支援遠端監測和預測性維護。醫療服務提供者應透過嚴格的培訓課程、完善的看護者支援系統以及基於夥伴關係的照護路徑，擴大居家照護計畫的覆蓋範圍，從而降低病患就醫的門檻。保險公司和政策制定者可以透過評估治療效果並調整報銷政策，促進可擴展的居家照護服務，從而對居家照護的普及產生重要影響。

透明地整合第二手資料、有針對性的一手訪談和嚴格的資料三角驗證，以確保獲得可靠且可操作的見解。

本報告的研究結合了系統性的二手文獻綜述和結構化的原始研究，以確保結論的平衡性和檢驗。二手研究階段納入了同行評審的臨床文獻、監管申報文件、醫療設備技術規範和政策文件，以建立對臨床實踐和技術性能的基礎性理解。為了進一步鞏固這一基礎，我們對包括臨床醫生、採購經理、醫療設備工程師和支付方在內的眾多相關人員進行了訪談，檢驗趨勢、掌握實際情況並識別新興的商業性趨勢。

臨床、技術和商業性訊號的明確整合，突顯了實現永續成長和改​​善患者預後的明確路徑。

透析產業正處於一個轉折點，其特點是技術創新融合、醫療服務模式轉型以及營運複雜性日益增加。在小型化設備和遠端監控的推動下，居家照護正成為許多患者替代機構照護的理想選擇，而先進的治療方法和材料也在提升特定患者群體的臨床治療能力。同時，政策變化和收費系統調整正在重塑採購和生產的優先事項，迫使相關人員採取更具韌性和靈活性的策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依治療方法分類的血液透析和腹膜透析市場

  • 血液透析
  • 腹膜透析
    • 自動腹膜透析
    • 持續性攜帶式腹膜透析

第9章 血液透析及腹膜透析市場：依透析方式分類

  • 在家工作
    • 輔助型
    • 自我管理
  • 設施內部

第10章 血液透析及腹膜透析市場：依技術分類

  • 傳統血液透析
  • 線上血液透析過濾
    • 混合流
    • 置換流

第11章 血液透析與腹膜透析市場：依產品類型分類

  • 濃縮液
  • 透析機
  • 透析器
    • 高通量
    • 低通量
  • 監控系統
  • 管組

第12章 依病患類型分類的血液透析和腹膜透析市場

  • 成人版
  • 老年人
  • 兒童

第13章 血液透析和腹膜透析市場：依最終用戶分類

  • 透析中心
  • 居家照護設施
  • 醫院
  • 專科診所

第14章 血液透析及腹膜透析市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 血液透析與腹膜透析市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 血液透析和腹膜透析市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國血液透析與腹膜透析市場

第18章：中國血液透析及腹膜透析市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Diaverum AB
  • Fresenius Medical Care AG & Co. KGaA
  • Jafron Biomedical Co., Ltd.
  • Medica SpA
  • Medtronic plc
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Rockwell Medical, Inc.
  • Toray Industries, Inc.
Product Code: MRR-8201ABF21C57

The Hemodialysis & Peritoneal Dialysis Market was valued at USD 95.91 billion in 2025 and is projected to grow to USD 102.50 billion in 2026, with a CAGR of 7.74%, reaching USD 161.73 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 95.91 billion
Estimated Year [2026] USD 102.50 billion
Forecast Year [2032] USD 161.73 billion
CAGR (%) 7.74%

A concise orientation to the evolving clinical, technological, and operational forces reshaping dialysis care delivery and stakeholder priorities

The treatment landscape for kidney failure is undergoing a meaningful evolution driven by technology, shifting care models, demographic pressures, and regulatory recalibrations. Hemodialysis remains a cornerstone of renal replacement therapy delivery in many health systems, while peritoneal dialysis is gaining renewed attention because of patient-centric advantages such as autonomy and reduced facility burden. Advances in machine automation, fluid formulations, and vascular access management continue to refine clinical practice, even as value-based payment models and home-care incentives reshape provider incentives.

Clinicians and operators must balance acute clinical imperatives with long-term sustainability. This means integrating digital monitoring to personalize therapy, strengthening supply chain partnerships to mitigate disruption, and rethinking training programs to scale home-based modalities. At the same time, manufacturers are investing in modular platforms, improved dialyzer membranes, and monitoring systems that enhance efficiency, safety, and data connectivity. As a result, stakeholders across the continuum are retooling strategies to meet changing patient preferences, regulatory expectations, and competitive dynamics, while preserving high standards of clinical effectiveness and operational reliability.

How home-first strategies, advanced device adoption, and sustainability imperatives are jointly rewriting care delivery models, supplier priorities, and payer incentives

The dialysis landscape is experiencing transformative shifts that affect clinical pathways, care delivery locations, and supplier ecosystems. Increasing acceptance of home modalities is one of the most consequential changes, supported by improvements in device ergonomics, remote patient monitoring, and structured caregiver training programs. This migration toward home-based care alters utilization patterns, creates demand for compact, user-friendly devices, and redefines service models to emphasize remote support and logistics.

Another transformative trend is the selective adoption of advanced dialysis technologies such as online hemodiafiltration and more sophisticated dialysis machine telemetry. These innovations are introducing differentiated clinical outcomes for specific patient cohorts and prompting payers and providers to consider revised protocols and reimbursement models. Concurrently, there is intensified focus on sustainability and cost containment, encouraging adoption of low-waste concentrates, reusable components where clinically appropriate, and lifecycle procurement strategies. Collectively, these shifts are prompting manufacturers to accelerate product differentiation, providers to reconfigure care pathways, and policymakers to revisit regulations and incentives that influence where and how dialysis care is delivered.

An integrated assessment of how tariff changes enacted in 2025 have reshaped procurement, sourcing strategy, and product design across the dialysis value chain

The tariff landscape introduced in the United States in 2025 has influenced procurement decisions, supplier networks, and cost structures across the dialysis value chain. Import duties and tariff-driven regulatory adjustments have contributed to increased attention on sourcing strategies, prompting health systems and manufacturers to re-evaluate supplier diversification, nearshoring, and inventory management policies. These shifts have had particular resonance for component-heavy product categories such as dialysis machines, monitoring systems, and tubing sets where international supply streams historically play a central role.

As organizations adjust to elevated import costs and compliance complexity, many have accelerated efforts to localize key manufacturing steps, renegotiate long-term supplier agreements, and redesign product bill-of-materials to reduce tariff exposure. Providers have responded by reassessing capital procurement timing and by intensifying value-based contracting conversations that account for total cost of ownership, including logistics and tariff-related expenses. Simultaneously, innovation strategies have been influenced as companies target modular designs and alternative raw materials to limit tariff sensitivity. The cumulative effect is a reconfiguration of commercial playbooks and an increased premium on supply chain transparency and contractual resilience.

Precise segmentation-driven intelligence linking clinical modality, product characteristics, end-user channels, and patient cohorts to strategic imperatives for optimized targeting

Segment-level insights reveal differentiated dynamics across treatment type, modality, technology, product, end-user, and patient cohorts that inform targeted strategic approaches. Based on Treatment Type, the comparative trajectories of Hemodialysis and Peritoneal Dialysis highlight contrasting operational footprints and patient experience profiles; within Peritoneal Dialysis, the distinctions between Automated Peritoneal and Continuous Ambulatory Peritoneal modalities influence device complexity, training intensity, and remote-monitoring needs. Based on Modality, the home versus in-center divide frames everything from capital allocation to staffing models, with the Home category further differentiated by Assisted Care and Self Care pathways that carry distinct clinical governance and reimbursement implications.

Based on Technology, the split between Conventional Hemodialysis and Online Hemodiafiltration underscores differing clinical evidence bases and infrastructure requirements, while the latter's Mixed Flow and Substitution Flow variants create nuanced clinical and capital considerations for adoption. Based on Product Type, categories such as Concentrates Fluids, Dialysis Machines, Dialyzers, Monitoring Systems, and Tubing Sets each follow separate innovation and regulatory timelines, and within Dialyzers the High Flux and Low Flux subtypes carry implications for therapy customization and supply inventory planning. Based on End User, distribution and service models vary significantly among Dialysis Centers, Home Care Settings, Hospitals, and Specialty Clinics, shaping commercial channels and aftermarket services. Based on Patient Type, distinct clinical pathways and device configurations are required for Adult, Geriatric, and Pediatric populations, affecting training protocols, dosing algorithms, and caregiver supports. Taken together, these segmentation lenses permit granular prioritization of investments, tailored go-to-market tactics, and differentiated clinical support programs that align with both patient needs and organizational capabilities.

How regional healthcare structures, reimbursement diversity, and supply chain realities are shaping differentiated adoption paths and go-to-market priorities globally

Regional dynamics continue to exert a defining influence on technology adoption, reimbursement mechanisms, and operational models across dialysis care. In the Americas, health system consolidation, established dialysis provider networks, and policy emphasis on value-based care drive demand for scalable in-center efficiency tools and a growing interest in home dialysis models that reduce facility burden. In contrast, Europe, Middle East & Africa present a mosaic of reimbursement environments and regulatory frameworks that influence adoption cadence for advanced technologies, with pockets of rapid uptake in markets that prioritize chronic disease management and remote care infrastructure.

Asia-Pacific encompasses a range of healthcare maturity levels, from advanced systems investing in digital health and localized manufacturing to emerging markets where access, affordability, and workforce constraints limit rapid modality transitions. Across regions, supply chain strategies, tariff exposure, and local manufacturing incentives influence product availability and pricing dynamics. The practical implication is that manufacturers and providers must calibrate regional go-to-market strategies, regulatory engagement, and service delivery models to the specific reimbursement incentives, infrastructure readiness, and patient population characteristics of each geography.

Competitive behaviors and strategic investments reveal a clear pivot toward integrated product-service platforms, clinical evidence generation, and regional capability expansion

Leading companies in the dialysis ecosystem are pursuing a mix of clinical differentiation, platform consolidation, and service-based models to sustain growth and defend margins. Product innovation focuses on smaller, more intuitive home devices, advanced dialyzer materials that improve biocompatibility and clearance, and integrated monitoring systems that enable remote titration of therapy and earlier intervention. Companies are also expanding service portfolios to include training programs, logistics management, and outcomes-based partnerships with providers, reflecting recognition that durable value often lies in the interplay between device performance and continuous clinical support.

Strategic alliances and selective acquisitions remain active pathways to accelerate capability-building, particularly in digital health, disposables manufacturing, and regional distribution. Firms are investing in real-world evidence generation to support differentiated clinical claims and payer negotiations, while also optimizing aftermarket service and consumables revenue streams. The competitive landscape rewards organizations that can combine robust clinical data, regulatory agility, and operational excellence to deliver seamless patient journeys across in-center and home settings.

Actionable strategic priorities for manufacturers, providers, payers, and supply chain leaders to strengthen resilience and accelerate modality transitions

Industry leaders should prioritize a set of targeted actions to navigate current headwinds and capture emerging opportunities across the dialysis continuum. Manufacturers ought to accelerate modular design initiatives that reduce reliance on tariff-sensitive components and simplify field servicing, while simultaneously enhancing digital telemetry to support remote monitoring and predictive maintenance. Providers should expand home modality programs through rigorous training curriculums, caregiver support frameworks, and partnership-based care pathways that lower barriers to patient uptake. Payers and policymakers can meaningfully influence adoption by calibrating reimbursement policies to reward outcomes and enable scalable home care delivery.

Supply chain leaders should pursue supplier diversification and nearshoring where feasible to reduce exposure to tariff volatility and logistical bottlenecks, and should increase investments in inventory analytics to balance cost and clinical readiness. Commercial teams must refine value propositions that articulate total cost of care and clinical outcomes rather than focusing on unit price alone, thereby enabling longer-term contracting that absorbs short-term tariff fluctuations. Finally, all stakeholders should commit to robust data governance and interoperability standards to ensure patient safety, facilitate remote care, and accelerate evidence generation that supports appropriate therapy selection.

A transparent synthesis of secondary evidence, targeted primary interviews, and rigorous data triangulation to ensure credible and actionable insights

The research underpinning this report combines systematic secondary review with structured primary engagement to ensure balanced, verifiable insights. The secondary phase incorporated peer-reviewed clinical literature, regulatory filings, device technical specifications, and policy documents to establish a baseline understanding of clinical practice and technology performance. This foundation was augmented by primary interviews with a cross-section of stakeholders including clinicians, procurement leaders, device engineers, and payers to validate trends, capture operational realities, and surface emerging commercial behaviors.

Data triangulation techniques were applied to reconcile discrepancies between reported performance claims, regulatory documentation, and frontline user experiences. Segmentation frameworks were iteratively refined to reflect clinically meaningful distinctions across treatment type, modality, technology, product, end-user, and patient cohorts. Limitations are acknowledged with transparency: where evidence was sparse, findings were flagged as emergent and recommendations were framed to accommodate scenario-based planning. Ethical considerations guided respondent confidentiality and conflict-of-interest screening during primary engagement to preserve the integrity of conclusions.

A definitive synthesis of clinical, technological, and commercial signals that highlights decisive pathways to sustainable growth and improved patient outcomes

The dialysis sector stands at an inflection point characterized by converging technological innovation, shifting care delivery models, and heightened operational complexity. Home modalities, fueled by device miniaturization and remote monitoring, present a compelling alternative to facility-centric care for many patients, while advanced therapies and materials are refining clinical capabilities for selected cohorts. At the same time, policy changes and tariff dynamics are reshaping procurement and manufacturing priorities, compelling stakeholders to adopt more resilient, agile strategies.

Looking ahead, organizations that invest in integrated product-service offerings, strengthen regional supply chain resilience, and generate robust real-world evidence are positioned to lead. Collaboration among manufacturers, providers, payers, and regulators will be essential to harmonize incentives and accelerate adoption of care models that improve patient experience while containing system costs. In short, success will depend on the ability to translate emerging clinical and technological promise into scalable, economically viable care pathways that meet the needs of diverse patient populations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hemodialysis & Peritoneal Dialysis Market, by Treatment Type

  • 8.1. Hemodialysis
  • 8.2. Peritoneal Dialysis
    • 8.2.1. Automated Peritoneal
    • 8.2.2. Continuous Ambulatory Peritoneal

9. Hemodialysis & Peritoneal Dialysis Market, by Modality

  • 9.1. Home
    • 9.1.1. Assisted Care
    • 9.1.2. Self Care
  • 9.2. In Center

10. Hemodialysis & Peritoneal Dialysis Market, by Technology

  • 10.1. Conventional Hemodialysis
  • 10.2. Online Hemodiafiltration
    • 10.2.1. Mixed Flow
    • 10.2.2. Substitution Flow

11. Hemodialysis & Peritoneal Dialysis Market, by Product Type

  • 11.1. Concentrates Fluids
  • 11.2. Dialysis Machines
  • 11.3. Dialyzers
    • 11.3.1. High Flux
    • 11.3.2. Low Flux
  • 11.4. Monitoring Systems
  • 11.5. Tubing Sets

12. Hemodialysis & Peritoneal Dialysis Market, by Patient Type

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Hemodialysis & Peritoneal Dialysis Market, by End User

  • 13.1. Dialysis Centers
  • 13.2. Home Care Settings
  • 13.3. Hospitals
  • 13.4. Specialty Clinics

14. Hemodialysis & Peritoneal Dialysis Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Hemodialysis & Peritoneal Dialysis Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Hemodialysis & Peritoneal Dialysis Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Hemodialysis & Peritoneal Dialysis Market

18. China Hemodialysis & Peritoneal Dialysis Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Asahi Kasei Medical Co., Ltd.
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International Inc.
  • 19.8. DaVita Inc.
  • 19.9. Diaverum AB
  • 19.10. Fresenius Medical Care AG & Co. KGaA
  • 19.11. Jafron Biomedical Co., Ltd.
  • 19.12. Medica S.p.A.
  • 19.13. Medtronic plc
  • 19.14. Nipro Corporation
  • 19.15. NxStage Medical, Inc.
  • 19.16. Rockwell Medical, Inc.
  • 19.17. Toray Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 196. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 229. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 240. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)